Whitehawk Therapeutics (WHWK) Share-based Compensation (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Share-based Compensation of $2.2 million for Q1 2026, up 30.54% year-over-year from $1.7 million in Q1 2025, and down 8.17% on a QoQ basis from $2.4 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 11 years of Share-based Compensation data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Share-based Compensation rose 30.54% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 16.3% YoY) and the FY2025 annual result came in at $9.9 million, down 8.91% from the prior year.
- Share-based Compensation slipped to $2.2 million in Q1 2026 per WHWK's latest filing, from $2.4 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.6 million in Q1 2024 and bottomed at $1.7 million in Q1 2025.
- The 5-year median for Share-based Compensation is $2.7 million (2023), against an average of $2.6 million.
- The widest annual swing landed in 2022, when Share-based Compensation soared 5630.77%; it then sank 53.19% in 2025.
- Tracing WHWK's Share-based Compensation over 5 years: stood at $2.9 million in 2022, then advanced by 8.4% to $3.1 million in 2023, then plunged by 40.41% to $1.9 million in 2024, then advanced by 28.8% to $2.4 million in 2025, then fell by 8.17% to $2.2 million in 2026.
- Per Business Quant, the three latest WHWK Share-based Compensation figures stand at $2.2 million (Q1 2026), $2.4 million (Q4 2025), and $2.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 2.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.19 Mn |
| Mar 31, 2026 | 2.19 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 2.84 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 3.11 Mn |
| Dec 31, 2023 | 3.11 Mn |
| Sep 30, 2023 | 3.05 Mn |
| Sep 30, 2023 | 3.05 Mn |
| Jun 30, 2023 | 3.05 Mn |
| Jun 30, 2023 | 3.05 Mn |
| Mar 31, 2023 | 2.74 Mn |
| Mar 31, 2023 | 2.74 Mn |
| Dec 31, 2022 | 2.87 Mn |
| Dec 31, 2022 | 2.87 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 2.24 Mn |
| Jun 30, 2022 | 2.24 Mn |
| Mar 31, 2022 | 1.78 Mn |
| Mar 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 648,000.00 |
| Sep 30, 2021 | 648,000.00 |
| Jun 30, 2021 | 39,000.00 |
| Jun 30, 2021 | 39,000.00 |
| Mar 31, 2021 | 36,000.00 |
| Mar 31, 2021 | 36,000.00 |
| Dec 31, 2020 | 39,000.00 |
| Dec 31, 2020 | 39,000.00 |
| Sep 30, 2020 | 34,000.00 |
| Sep 30, 2020 | 34,000.00 |
| Jun 30, 2020 | 308,341.00 |
| Jun 30, 2020 | 308,341.00 |
| Mar 31, 2020 | 327,467.00 |
| Mar 31, 2020 | 327,467.00 |
| Dec 31, 2019 | -786,403.00 |
| Dec 31, 2019 | -786,403.00 |
| Sep 30, 2019 | 645,899.00 |
| Sep 30, 2019 | 645,899.00 |
| Jun 30, 2019 | 604,661.00 |
| Jun 30, 2019 | 604,661.00 |
| Mar 31, 2019 | 621,685.00 |
| Mar 31, 2019 | 621,685.00 |
| Dec 31, 2018 | 667,972.00 |
| Dec 31, 2018 | 667,972.00 |
| Sep 30, 2018 | 806,411.00 |
| Sep 30, 2018 | 806,411.00 |
| Jun 30, 2018 | 877,757.00 |
| Jun 30, 2018 | 877,757.00 |
| Mar 31, 2018 | 1.08 Mn |
| Mar 31, 2018 | 1.08 Mn |
| Dec 31, 2017 | 255,141.00 |
| Dec 31, 2017 | 255,141.00 |
| Sep 30, 2017 | 127,359.00 |
| Sep 30, 2017 | 127,359.00 |
| Jun 30, 2017 | 111,524.00 |
| Jun 30, 2017 | 111,524.00 |
| Mar 31, 2017 | 155,385.00 |
| Mar 31, 2017 | 155,385.00 |
| Dec 31, 2016 | 130,063.00 |
| Dec 31, 2016 | 130,063.00 |
| Sep 30, 2016 | 113,498.00 |
| Sep 30, 2016 | 113,498.00 |
| Jun 30, 2016 | 119,550.00 |
| Jun 30, 2016 | 119,550.00 |
| Mar 31, 2016 | 125,215.00 |
| Mar 31, 2016 | 125,215.00 |